Cite
HARVARD Citation
Bradbury, P. et al. (2018). Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy. Lung cancer. pp. 142-148. [Online].